Graph-Based Counterfactual Causal Inference Modeling for Neuroimaging Analysis.
Haixing Dai,Mengxuan Hu,Qing Li,Lu Zhang,Lin Zhao,Dajiang Zhu,Ibai Diez,Jorge Sepulcre,Fan Zhang,Xingyu Gao,Manhua Liu,Quanzheng Li,Sheng Li,Tianming Liu,Xiang Li
DOI: https://doi.org/10.1007/978-3-031-47425-5_19
2023-01-01
Abstract:Alzheimer's disease (AD) is a neurodegenerative disorder that is beginning with amyloidosis, followed by neuronal loss and deterioration in structure, function, and cognition. The accumulation of amyloid-beta in the brain, measured through 18F-florbetapir (AV45) positron emission tomography (PET) imaging, has been widely used for early diagnosis of AD. However, the relationship between amyloid-beta accumulation and AD pathophysiology remains unclear, and causal inference approaches are needed to uncover how amyloid-beta levels can impact AD development. In this paper, we propose a Graph-VCNet for estimating the individual treatment effect with continuous treatment levels using a graph convolutional neural network. We highlight the potential of causal inference approaches, including Graph-VCNet, for measuring the regional causal connections between amyloid-beta accumulation and AD pathophysiology, which may serve as a robust tool for early diagnosis and tailored care.